Patent · US Active

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

US12059420B2 · kind B2 · utility

0Cited by

8References

6Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

James Aaron Balog · Lambertville, US
Jay A. Markwalder · New London, US
Weifang Shan · Princeton, US
David K. Williams · Cinnaminson, US
Susheel Jethanand Nara · Mumbai, IN
Saumya Roy · Bengaluru, IN
Soodamani Thangavel · Krishnagiri, IN
Srinivas Cheruku · Bengaluru, IN
Ramesh Kumar Sistla · Bengaluru, IN

Key dates

Filing date	Jul 22, 2019
Grant date	Aug 13, 2024
Priority date	—
Expiry date	Jan 23, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compounds of formula (I): wherein all of the variables are as defined herein. These compounds are inhibitors of indoleamine 2,3-dioxygenase (IDO), which may be used as medicaments for the treatment of proliferative disorders, such as cancer, viral infections and/or autoimmune diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.